Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.72 USD | -0.14% | -10.96% | +75.16% |
Mar. 06 | Transcript : Inovio Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 06, 2024 | |
Mar. 06 | Inovio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 604K | Sales 2025 * | 8.03M | Capitalization | 251M |
---|---|---|---|---|---|
Net income 2024 * | -99M | Net income 2025 * | -93M | EV / Sales 2024 * | 415 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 31.2 x |
P/E ratio 2024 * |
-2.78
x | P/E ratio 2025 * |
-3.55
x | Employees | 122 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.78% |
Latest transcript on Inovio Pharmaceuticals, Inc.
1 day | -0.14% | ||
1 week | -10.96% | ||
Current month | +20.99% | ||
1 month | +35.18% | ||
3 months | +136.33% | ||
6 months | +122.22% | ||
Current year | +75.16% |
Managers | Title | Age | Since |
---|---|---|---|
Jacqueline Shea
CEO | Chief Executive Officer | 58 | 19-03-24 |
Peter Kies
DFI | Director of Finance/CFO | 60 | 02-05-31 |
Chief Tech/Sci/R&D Officer | - | 07-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Benito
CHM | Chairman | 79 | 03-11-30 |
Lota Zoth
BRD | Director/Board Member | 64 | 19-01-02 |
Jay Shepard
BRD | Director/Board Member | 66 | 20-01-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 10.72 | -0.14% | 333,404 |
24-03-15 | 10.74 | -0.69% | 312,279 |
24-03-14 | 10.81 | -3.91% | 338,002 |
24-03-13 | 11.25 | -2.26% | 934,767 |
24-03-12 | 11.51 | -4.40% | 598,731 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+75.16% | 251M | |
+9.72% | 46.21B | |
+35.14% | 40.04B | |
+4.84% | 39.92B | |
-9.43% | 28.33B | |
+17.47% | 27.43B | |
-22.99% | 18.57B | |
+10.88% | 13.46B | |
+27.53% | 12.02B | |
-6.84% | 11.3B |